Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
18/20
Brand Signal
6/15
Depth
3/15
5-Axis Cultural Radar
Two major biopharmaceutical media accounts currently handled by Omnicom—Bristol Myers Squibb and Gilead Sciences—are in review or set to go into review.
